| P/E (FY) | — | Sales (TTM) | $95.1M |
| Earnings (TTM) | -$131.6M | ROE | — |
| Net Margin | −190.28% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Kestra Medical Technologies is a wearable medical device and digital healthcare company focused on cardiovascular disease using monitoring and therapeutic intervention technologies. It develops and commercializes its Cardiac Recovery System platform, which integrates monitoring, therapeutic treatment, digital health, and patient support, including the ASSURE wearable cardioverter defibrillator for patients at elevated risk of sudden cardiac arrest. The company is based in Kirkland, Washington.
| Market Cap | $1.40B | Trading Days | 340 |
| 52W High | 30.00 |
| 52W Low | 14.10 |
| % Off High | −20.47% |
| YTD | −10.03% | 1Y | 44.61% |
| Since incept. (ann.) | 6.55% |
| Ann. Volatility (1Y) | 66.70% | Ann. Volatility (3Y) | 67.25% |
| Sharpe (1Y) | 0.91 | Sharpe (3Y) | 0.43 |
| Max Drawdown (1Y) | −36.20% | Max Drawdown (3Y) | −43.74% |
| Beta (3Y, vs SPY) | 0.58 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | $1.41B | — |
| AORT | ARTIVION, INC. | $1.31B | 128.6 |
| INSP | Inspire Medical Systems, Inc. | $1.50B | 10.6 |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.54B | — |
| TNDM | TANDEM DIABETES CARE INC | $1.22B | — |
| IRMD | IRADIMED CORP | $1.21B | 54.2 |
| NVCR | NovoCure Ltd | $1.90B | — |
| PRCT | PROCEPT BioRobotics Corp | $1.03B | — |
| UFPT | UFP TECHNOLOGIES INC | $2.00B | 29.5 |
| ATRC | AtriCure, Inc. | $2.02B | — |
| BVS | Bioventus Inc. | $910.4M | 40.0 |
| HTFL | Heartflow, Inc. |
| $2.21B |
| — |
